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In 1953, Medawar and his colleagues (1) induced tissue transplantation toler- 
ance  in  mice  by  injecting  allogeneic  bone  marrow  cells  intravenously  into 
newborn  recipients.  Permanent  chimerism  was  established  without  runt  dis- 
ease.  Recipients  accepted donor skin grafts but rejected third-party grafts (2). 
These experimental results were predicted by Burnet and Fenner  (3). 
Although  chimerism can be established  by injecting  allogeneic  bone  marrow  into 
lethally irradiated adult mice, a  lethal graft vs. host disease ensues in most strains of 
mice (4). Even in those strains in which minimal graft vs. host disease is observed, late 
deaths  (>100  days  after transplantation)  occur  in  a  high  proportion  (up to  40%) of 
recipients (5). Recently,  stable chimerism and specific tolerance have been induced in 
adult  mice  and  rats  by  lethal  whole  body  irradiation  of recipients  followed by  the 
intravenous infusion of allogeneic fetal liver cells (6) or adult bone marrow cells treated 
in vitro to remove thymus-derived (T) cells and/or T-cell precursors (7, 8). Little or no 
clinical evidence of graft vs. host disease was noted in the latter studies.  In addition, 
adult  rats have been rendered  tolerant to allogeneic cells after treatment with anti- 
idiotype antibody directed against receptor sites for AgB alloantigens (9). 
Successful clinical application of techniques developed for the induction of transplanta- 
tion tolerance in laboratory rodents  requires  that:  (a) the recipient treatment can be 
relatively safe in humans, (b) the technique can be used in outbred species, and (c) long- 
term survival of allogeneic organ grafts can be achieved. Thus, animal models of tissue 
tolerance induction which depend upon lethal irradiation may not be practical for clinical 
organ transplantation due to severe and sometimes fatal side effects of such treatment 
(10, 11). The requirement for the use of inbred animals as donors of large numbers of fetal 
cells and organ grafts (6, 8), or as transplant recipients (7) is also impractical. Finally, 
those tolerization regimens which prolong organ graft survival in rodents for only 1-2 mo 
(9), do not meet the goals of long-term graft survival in humans. 
The  present  report  describes  a  new  technique  for the  induction  of specific 
transplantation tolerance in mice using fractionated total lymphoid irradiation 
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(TLI). 1 This radiotherapy regimen is used in the treatment of human malignant 
lymphomas, and is associated with few severe side effects (12). Mice treated with 
TLI accepted H-2 incompatible bone marrow grafts for at least 250 days without 
clinical  evidence  of graft  vs.  host  disease  in  a  completely  allogeneic  strain 
combination. Specific long-term tissue tolerance was documented in the stable 
chimeras by transplantation of appropriate skin allografts, and by examination 
of the in vitro response  to allogeneic  lymphocytes  [mixed leukocyte reaction 
(MLR)]. The possible application of these findings to clinical organ transplanta- 
tion is discussed. 
Materials and Methods 
Animals.  Inbred male and female BALB/c (I-1-2  dl~) mice, 6- to 8-too old, were used as irradi- 
ated recipients of allografts. Female C57BL/Ka (H-2~1~), C3H/He (H-2k~k), and (BALB/c x  C57BL/ 
Ka)F1 (1"1-2  dlb) mice were the donors of bone marrow cells and allogeneic skin grafts. All mice were 
bred  in  pathogen-free  conditions  in  the  Division  of Radiobiology,  Department  of Radiology, 
Stanford University, Stanford,  Calif., but were kept in conventional housing during all experi- 
ments. 
Radiation Source.  X rays were delivered by a  Philips unit (250 kV,  15 mA; Philips Medical 
Systems, Inc., Mount Vernon, N. Y.) at a rate of 40 rads/min. The source to skin distance was 60 
cm, and 0.25 mm Cu plus 1.0 mm A1 filters were used. Dosimetry was verified using a calibrating 
ionizing chamber, and by lithium fluoride thermoluminescence dosimeters. 
Radiation Procedure.  BALB/c mice were anesthetized with pentobarbital for proper position- 
ing in an apparatus that was designed to expose the major lymph nodes (submandibular cervical, 
axillary,  inguinal,  and mesenteric),  the thymus,  and the spleen. Most of the skull, ribs, lungs, 
hind legs, and tail were shielded with lead (Fig. 1). Unless otherwise noted, all mice received 200 
rads/day five times a  week to a  total dose of 3,400 rads. 
Skin Grafting.  A full thickness skin graft was transplanted to the flank of several groups of 
irradiated  and  control  mice  (13).  The grafts were followed by daily inspection and  palpation. 
Rejection was taken as the time of complete sloughing, or when a dry scab was formed. 
Splenectomy.  In some experiments,  splenectomy was performed 3 wk before the irradiation 
regimen to allow for complete recovery from the surgical  procedure.  The  spleen  was  exposed 
through  a  midline abdominal  incision and  the  pedicle tied off with  4-0  silk.  The pedicle was 
severed distally, and the incision was closed with silk sutures. 
Peripheral Blood.  Mice were bled periodically from the retro-orbital veins. Blood was collected 
and  pooled from groups  of experimental  and  control mice using sterile glassware  coated with 
preservative-free heparin. 
Purification of Peripheral Blood Lymphocytes (PBL).  Peripheral blood was collected into dry 
heparinized  glass  tubes,  and  diluted  1:5  (vol/vol) with  phosphate-buffered  saline  (PBS).  The 
suspension was layered on a Ficoll-Hypaque gradient (14). After centrifugation for 40 rain at room 
temperature,  cells were aspirated from the PBS-Ficoll interface and washed in PBS. 
PBL Counts.  Peripheral blood was diluted in acetic acid (2%) and nucleated cells were counted 
in a standard hemocytometer. Absolute PBL counts were calculated by multiplying the percentage 
of lymphocytes in blood smears treated with Wright's strain, and the nucleated (white) blood cell 
count.  Mean  normal  values for PBL,  and  leukocytes  (WBC) were obtained  from pooled blood 
samples taken from a single group of 12 control mice on 14 different occasions during a 6 mo period. 
Quantitation of T Lymphocytes.  The absolute T-cell count in the peripheral blood was calcu- 
lated from the percentage of T lymphocytes, and the absolute lymphocyte count. The percentage of 
T cells was determined using a dye-exclusion microcytotoxicity test with a noncongenic anti-Thy 
1.2 antiserum  (AKR/J anti-C3H/He thymocyte antiserum)  (15). FicoU-Hypaque-purifiod PBL were 
washed twice in PBS,  and contaminating erythrocytes (RBC) were lysed with ammonium chlo- 
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FIG.  1.  A  double  exposure  X-ray  film  of an  anesthetized  mouse  in  a  lead  apparatus 
designed for exposure of the major lymphoid organs to irradiation. 
ride. The lymphocytes were resuspended in medium 199 containing 5% heat-inactivated fetal calf 
serum (FCS) to a concentration of 2  x  106 ml.  10 ~l of the lymphocyte suspension was incubated 
with 10  ~1 of anti-Thy 1.2 antiserum (1:10)  for 30 min at room temperature.  5  ~l of guinea pig 
complement (C') (final concentration 1:5) was added for an additional 45 rain at room temperature. 
The cells were spun at 250 g  for 5 min and resuspended in 15 ~1 of medium 199. Trypan blue was 
added before each reading. 
Quantitation of Immunoglobulin  (Ig)-Bearing Lymphocytes (B Lymphocytes).  Absolute B-cell 
counts in the peripheral blood were calculated from the percentage of B  lymphocytes,  and the 
absolute lymphocyte count.  Ig-bearing cells were identified by a  two-stage immunofluorescent- 
staining procedure using a  polyvalent rabbit-anti-mouse Ig, 2 and a  fluorescein-conjugated goat- 
anti-rabbit Ig antiserum (Meloy Laboratories Inc., Springfield, Va.) as described previously (16). 
PBL were stained in suspension, and smeared onto glass slides. The percentage of fluorescent cells 
was determined after counting a  total of 100-200 small cells at 400  magnification using a  Zeiss 
microscope  (Carl  Zeiss,  Inc.,  New  York)  with a  tungsten light source and fluorescein isothio- 
cyanate excitation filter. 
MLR.  The proliferative response of pooled PBL from normal and irradiated BALB/c mice to 
allogeneic stimulator cells was measured at different times after TLI (17).  1 ×  106 responding cells 
were cultured in 0.2 ml flat bottom microculture wells  (Microtest II tissue culture plate, Falcon 
3040;  Falcon  Plastics,  Div.  of BioQuest,  Oxnard,  Calif.)  with  1  x  10  e stimulator  lymphocytes 
isolated  from  peripheral  lymph  nodes.  Stimulator  cells  were  inactivated by  a  single  in  vitro 
exposure to 3,400 reds from a  radioactive cesium-137 source  (Mark I  model 25 irradiator; J.  L. 
Shepherd  and  Associates,  Glendale,  Calif.).  Irradiated  syngeneic  lymph  node  cells  served  as 
stimulator cells in negative controls for each experiment. The culture medium contained RPMI 
1640 medium supplemented with human AB serum (10%), glutamine (2 mM), 2-mercaptoethanol 
(5  x  10  -5  M),  penicillin  (100  U/ml),  and  streptomycin  (100  ~g/ml).  Tissue  culture  media  and 
reagents  were  purchased  from  Grand  Island  Biological  Co.,  Grand  Island,  N.  Y.  Cells  were 
incubated 37°C with 5% CO2-air mixture in a humidified incubator for 72 h, and then pulsed for 16- 
18 h with 1/~Ci of [3H]thymidine (6.7 Ci/mmol; New England Nuclear, Boston, Mass.) per culture. 
Cells were subsequently collected on paper filters using a  multiple sample harvester (Mash II; 
Microbiological Associates, Inc., Bethesda, Md.). Filters were dried, dispensed into vials contain- 
ing 3 ml of scintillation fluid, and counted in a  Beckman liquid scintillation counter (Beckman 
Instruments, Inc., Fullerton, Calif.). The MLR of lymph node cells from allogeneic bone marrow 
chimeras was assayed using 0.5 x  106 responding cells and i  × 106 stimulating cells in 0.2 ml round 
bottom microculture wells (Microtiter plates, 1-220-24 A; Cooke Laboratory Products Div., Dyna- 
tech Laboratories Inc.,  Alexandria,  Va.).  Otherwise,  the  MLR procedure  was  identical to that 
described above. 
2 Polyvalent rabbit-anti-mouse Ig was kindly supplied by Dr. L. A. Herzenberg, Department of 
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Blastogenic Response  to Phytohemagglutinin  (PHA).  2  ×  105 purified PBL from irradiated 
mice were aliquoted into 0.2 ml microculture wells containing RPMI 1640 supplemented with FCS 
(10%), glutamine (2 mM), penicillin (100 U/ml), and streptomycin (100  ~g/ml).  PHA  (Purified- 
Phytehemagglutinin; Burroughs-Wellcome, London, England) was added at the optimal concen- 
tration of 0.6 ~tg/ml.  Cultures were done in triplicate.  PBL from age- and sex-matched normal 
mice  were  used  as  controls  in  each  experiment.  The  cultures  were  pulsed  with  1  /~Ci  of 
[3H]thymidine after 72 h, and uptake was measured as described in the previous section. Results 
were expressed as the percentage of the normal response (cpm experimental/cpm normal ×  100) in 
order to correct for considerable variability in the absolute [3H]thymidine uptake (cpm) in controls 
in different experiments during the long observation period. Background values for experimental 
and control groups were less than 1,000 cpm. 
Blastogenic Response to Concanavalin A  (Con A).  4  x  105 purified PBL from irradiated mice 
were added to microculture wells in 0.2 ml tissue culture medium as described in the previous 
section.  Con A  (Pharmacia Fine Chemicals,  Ltd.,  Uppsala,  Sweden)  was added at an optimal 
concentration of 2.5/~g/ml.  PBL from age- and sex-matched normal mice were assayed concomi- 
tantly, and all cultures were done in triplicate. [3H]thymidine uptake was measured as before, and 
results were expressed as the percentage of the normal response (cpm experimental/cpm control × 
100).  Background values for experimental and control groups were less than 1,000 cpm. 
Infusion of Bone Marrow (BM) Cells into BALB/c Mice Given TLI.  BM cells were obtained by 
flushing minimal essential medium (MEM) through the shafts of the femori and tibiae of donor 
mice. Cells were washed once and resuspended in MEM. Aliquots of 0.25 ml medium containing 
107 nucleated cells were injected intravenously to recipient mice. 
Assays for Chimerism 
CHIMERISM OF LYMPHOCYTES.  Chimerism of PBL, spleen, lymph nodes, and BM was assayed 
using an in vitro microcytotoxicity test (18) to determine the percentage of lymphocytes carrying 
host or donor H-2 surface markers. Lymphocytes from all of the above sources were purified on a 
Ficoll-Hypaque gradient, washed three times in PBS with 5% FCS,  and resuspended at 1 ×  106 
cells/ml in PBS with 5% FCS. 2 #1 of the cell suspensions, and 2 ~tl of specific anti-H-2 antiserum 
diluted in PBS were incubated in microtest plates (Falcon 3034; Falcon Plastics, Div. of BioQuest) 
for 15 min in a humidified atmosphere at 37°C.  Cells were washed once with cold, serum-free PBS, 
and incubated for 30 min at 37°C  in 2  ~tl of rabbit C'  diluted  1:6 with PBS.  The reaction was 
terminated by the addition of 25 ~l cold PBS containing 5% FCS, and Nigrosin at a concentration 
of 0.1%.  Doubling dilutions of anti-H-2 antisera were made starting at 1:10. 
The percentage of dead cells was determined using an inverted microscope (number of stained 
cells per total number of cells ×  100). Test plates were read blindly by two independent observers. 
The percent cytotoxicity for a  given pool of cells is reported as the mean of several values on the 
plateau portion of the dilution curve. Nonspecific cell death after incubation in C' alone was -<5%. 
CHIMERISM OF RBC.  Blood was collected into acid citrate dextrose. RBC were washed twice in 
PBS,  and made up  as  a  2% solution in  PBS.  Serial two-fold dilutions of the specific anti-H-2 
alloantisera were  made  in  1%  polyvinylpyrrolidone in  PBS with  0.1%  bovine serum  albumin 
(freshly added) in a  final vol of 0.2 ml in glass tubes (10 x  75).  An aliquot of 50 #1 of the RBC 
suspension was  added to each tube,  and agglutination was read 2  h  after incubation at room 
temperature.  Tubes  were  smoothly  stroked  across  the length of an  Rh typing box,  and  RBC 
agglutination was scored on a  scale of 1+ to 4+ by two independent observers. Data express the 
maximal hemagglutination that was obtained at the optimal titer of alloantiserum. (B10.A(5R) × 
A)F1 anti-B10.A(2R) antiserum was used to detect H-2 b~b and H-2 bid target cells,  and B10 anti- 
B10.D2 antiserum was used to detect H-2 d~d and H-2 b~d target cells  3 in both the cytotoxicity and 
hemagglutination assays. 
Prolongation  of C57BL/Ka 
Different Total Doses of TLI. 
Results 
Skin  Graft  Survival  on  BALB/c  Mice  Given 
TLI was administered  to three  groups of mice 
3 The antisera were kindly supplied by Dr. D. B. Murphy and Dr. H. O. McDevitt, Department 
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TABLE  I 
C57BL/Ka Skin Survival (in Days) on BALB/c Mice after Pretreatment with Different 
Radiation Protocols 
Mean  No.  of 
Procedure  <20  21-30  31-40  41-50  51-60  61-70  >70  mice  survival  Range 
time 
Control  12 
Splenectomy  alone  8 
Subdiaphragmatic  irradia-  8  6 
tion  (3,400 rads) 
TLI 3,400 rads  5  4  5 
TLI  3,400  rads  +  splenec-  2  3 
tomy 
TLI 3,400 rads with thymic  9  1 
sheilding 
TLI 3,400 rads  +  thymic ir-  2  6  3 
radiation 
12  10.7  10-13 
8  11.2  9-15 
14  19.9  14-26 
2  16  49.1  35-67 
5  52.0  47-56 
10  18.0  16-25 
1  12  52.0  24-96 
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FIG.  2.  C57BL/Ka skin allograft survival (mean + range) in BALB/c mice pretreated with 
different cumulative doses of total lymphoid irradiation. 
with cumulative radiation doses of 1,400 (7 mice), 2,400 (15 mice), and 3,400 rads 
(16 mice), respectively.  The mean survival time of C57BL/Ka skin allografts on 
12 untreated BALB/c mice was 10.7 days (range,  10-13 days) (Table I). As can 
be seen in Fig. 2, the effect of TLI on skin allograft survival was dose dependent. 
Doses of 3,400,  2,400,  and  1,400 rads prolonged the mean survival of the skin 
allografts to 49.1,  27.6,  and 18.4 days, respectively.  Doses of radiation greater 
than 3,400 rads were not used in order to avoid radiation damage to visceral 
organs such as the gastrointestinal  tract,  kidneys,  and liver.  The  irradiation 
procedure alone (3,400 rads) did not result in any mortality during an observa- 
tion period of >250 days. 
Prolongation of Skin Allograft Survival on Mice Given Regional Lymphoid 
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of TLI at the same cumulative dose of 3,400 rads.  14  mice were given sub- 
diaphragmatic  irradiation  using  the  same  apparatus  as  before except that 
additional lead was added to shield all areas above the diaphragm. C57BL/Ka 
skin allograft survival was significantly shorter after regional (19.9 days) as 
compared to total (49.1 days) lymphoid irradiation (Table I). 
Effect of Splenectomy  and  TLI on Skin Allografl Survival.  Five BALB/c 
mice were splenectomized 3 wk before TLI. The mean survival time of C57BL! 
Ka  skin  allografts on the  irradiated and  splenectomized hosts  was  52  days 
(range, 47-56 days) (Table I). Thus, splenectomy  produced no significant further 
prolongation of allograft survival as compared to TLI alone. 
Effect of TLI with Thymic Shielding on Skin Allograft Survival.  In order to 
determine the contribution of thymic irradiation to the prolongation of C57BL/ 
Ka skin allograft survival after TLI,  10  BALB/c mice were given TLI with 
additional lead shielding placed over the thymus. Table I shows that 9 out of 10 
mice in this group rejected their grafts within 20 days. On the other hand, all of 
16 mice given TLI without thymic shielding maintained their skin grafts for at 
least 35 days. 
Effect  of TLI and Additional  Thymic  Irradiation  on  Skin Allografl Sur- 
vival.  The effect of thymic irradiation in addition to TLI was studied in  12 
BALB/c mice. A single dose of 2,000 rads was administered to the mediastinum 
upon completion of TLI.  C57BL/Ka  skin allografts were transplanted on the 
following day. The mean survival time of skin allografts was 52 days (range, 24- 
96 days) (Table I). No thymic tissue could be identified by macroscopic inspection 
of the  mediastinum in  three  mice that  were sacrificed after skin  allograft 
rejection. The results show that additional thymic irradiation did not prolong 
allograft survival beyond that observed with TLI alone. 
Transplantation  of Semiallogeneic  Bone  Marrow  to BALB/c  Mice  Given 
TLI.  Eight BALB/c mice were transfused with 107  (BALB/c  ×  C57BL/Ka)FI 
nucleated BM cells, 1 day after completion of TLI (3,400 rads). C57BL/Ka  skin 
was grafted 1 day after BM transfer. Chimerism was documented 180 days after 
BM transplantation by H-2 typing of peripheral blood, spleen, and BM lympho- 
cytes, using a dye exclusion microcytotoxic  assay (Table II), and byH-2 typing of 
RBC  using  a  hemagglutination assay  (Table  II).  Recipient- and donor-type 
lymphocytes were simultaneously present in the peripheral blood (23 and 77%, 
respectively), BM (40 and 60%, respectively), and spleen (20 and 80%, respec- 
tively). Both recipient- and donor-type RBC were detected in all chimeric mice 
(Table II). 
Transplantation of Allogeneic Bone Marrow to BALB/c Mice Given TLI.  A 
group of 18  BALB/c mice were given TLI  (3,400 rads),  and an  intravenous 
injection of 107 C57BL/Ka BM cells within 24 h after irradiation was completed. 
C57BL/Ka  skin was grafted on the following day. After 6 mo, chimerism of 
lymphocytes and RBC was assayed in 15 mice that survived. Both donor and 
recipient lymphocytes and RBC  were detected in eight mice with intact skin 
grafts (Table III).  Pooled PBL showed 44% donor-type (H-2  b) lymphocytes, and 
52%  recipient-type lymphocyte (H-2~).  The  lymphoid organs  that  had been 
exposed to irradiation contained predominantly donor-type lymphocytes. Thus, 
88% of spleen lymphocytes, >95% of lymph node lymphocytes, and 80% of bone 40  SKIN  AND  MARROW  TRANSPLANTATION  AFTER  TLI 
TABLZ II 
H-2 Typing of Lyrnphocytes and Red Blood Cells of TLI-Treated  BALB/c Mice 6 Mo 
After Serniallogeneic Bone Marrow Transplantation 
Source of  Lymphocytes and RBC 
Lymphocyte typing 
Percent kill* 
RBC  typing 
Hemagglutination$ 
Anti-H-2  d  Anti-H-2  b  Anti-H-2  d  Anti-H-2  b 
serum  serum  serum  serum 
BALB/c (H-2d~d), peripheral blood§  >95  <5  +3  0 
C57BL/Ka (H-2bJb), peripheral blood§  <5  >95  0  +3 
(BALB/c x  C57BL/Ka)Fl(H-2d~b), pe-  >95  >95  +3  +3 
ripheral blood§ 
BALB/c  +  TLI  +  107  (BALB/c  x 
C57BL/Ka)F1  BM cells 
Peripheral blood  >95§  77§  +3,  +311  +1,  +111 
Spleen¶  >98  80 
B.M.¶. **  >98  60 
* Percent kill  at the plateau of  the dilution curve. 
Hemagglutination at the optimal titer  of  anti H-2 antisera, graded 0 to +3. 
§ Tested on pooled blood, seven mice. 
II  Tested on individual blood samples, two mice. 
¶ Tested on one individual sample. 
** Lymphocytes pooled from exposed and shielded bones (humerus, femur, and tibia). 
TABLZ III 
H-2 Typing of Lymphocytes  and RBC of TLI-Treated  BALB/c Mice 6 Mo After 
Allogeneic Bone Marrow Transplantation 
Source of  lymphocytes and RBC 
Lymphocyte typing 
Percent Kill* 
RBC  typing 
Hemagglutination$ 
Anti-H-2  d  Anti-H-2  b  Anti-H-2  d  Anti-H-2  b 
serum  serum  serum  serum 
BALB/c (H-2  did), peripheral blood§  >98  <2 
C57BL/Ka(H-2~/b), peripheral blood§  <2  >95 
BALB/c +  TLI  +  107 C57BL/Ka BM 
cells 
Peripheral blood  52§  44§ 
Spleen¶  30  88 
Lymph nodes¶  15  >95 
Bone marrowS (shielded: femur and  65  29 
tibia) 
Bone marrow¶ (exposed: humerus)  26  80 
+3  0 
0  +3 
+2 to +311  +1 to +:~1 
* Mean of  percent kill  at the plateau of  each dilution curve. 
Hemagglutination at the optimal titer  of  anti-H-2 serum, graded 0 to ÷3. 
§ Tested on pooled blood, seven mice. 
II  Tested on individual samples, seven mice. 
¶ Tested on a pool of  two mice. 
marrow lymphocytes isolated from bones exposed to irradiation (humeri) carried 
donor-type  (H-2 b) surface  markers  (Table III).  Conversely,  shielded bones  (fe- 
mori and tibiae) contained mostly recipient-type (H-2 d) lymphocytes  (65% H-2 d 
vs.  29% H-2b).  Donor-type lymphocytes were undetectable  in blood pooled from S.  SLAVIN~  S.  STROBER,  Z.  FUKS,  AND  H.  S.  KAPLAN 
TABLE  IV 
Fraction of  BALB/c Mice with Intact C57BL/Ka Skin Grafts at 250 Days After TLI 
and Semiallogeneic or Allogeneic Bone Marrow Transplantation 
41 
Recipient treatment 
No. of mice  No. of mice  with intact 
grafts  transplanted 
TLI 3,400 rads, i.v. 107 (BALB/c × C57BL/Ka)F1 BM, 
C57BL/Ka skin graft 
TLI 3,400 rads, i.v. 107 C57BL/Ka BM, C57BL/Ka  skin 
graft 
TLI  3,400 rads, i.v. 107  irradiated  C57BL/Ka BM, 
C57BL/Ka skin graft 
7  8 
8  15" 
0  6 
* Seven skin grafts were rejected between 34 and 90 days. 
the seven mice which rejected their C57BL/Ka skin allografts 34-90 days after 
transplantation  (Table IV). 
Lack of Graft vs. Host Disease in Allogeneic Bone Marrow Chimeras.  No 
signs  of graft  vs.  host  disease  were  clinically  detectable  among  BM  allo- 
transplant recipients.  15 of 18 mice survived more than 200 days without ruffled 
fur,  hunched  back,  or diarrhea.  Although  animals  lost up to 25-30%  of body 
weight during irradiation,  1 mo after bone marrow infusion recipients returned 
to the weight of age-matched controls.  Three mice died at 34,  46, and 82 days 
after BM transplantation.  Autopsy of the dead mice revealed:  (a)  interstitial 
pneumonitis,  (b) hemorrhagic,  fibronecrotic enteritis  of the jejunum,  and  (c) 
vascular damage of small vessels of the liver, and mucosa of the small intestine. 
There was no splenomegaly. Similar mortality rates and autopsy findings were 
recorded  simultaneously  among  untreated  BALB/c mice  in  the  same  mouse 
room. The cause of death in both cases was not determined. 
Specific  Transplantation  Tolerance  in  Chimeric  Recipients.  Seven out of 
eight BALB/c mice given (BALB/c x  C57BL/Ka)F1 BM cells after TLI treatment 
maintained C57BL/Ka skin allografts permanently with full hair growth (>250 
days).  One mouse rejected the skin graft after 95 days (before chimerism  was 
tested) (Table IV). The specificity of tolerance to the allogeneic skin graft was 
tested by transplanting  C3H/He skin to four recipients 200 days after the first 
C57BL/Ka skin transplantation.  Rejection of C3H/He skin grafts occurred after 
a  mean of 8.6 days (range,  7-13 days) while the adjacent C57BL/Ka skin grafts 
remained intact in all mice. 
Eight  chimeric  BALB/c  mice  with  C57BL/Ka  BM  cells  maintained  their 
C57BL/Ka skin allografts permanently (>250 days). The specificity of tolerance 
of the chimeras to donor-type alloantigens was tested in the one-way MLR using 
pooled lymph node cells from two C57BL-Ka-BALB/c chimeras sacrificed after 9 
mo. Lymphocytes from the chimeras responded to two types of unrelated stimu- 
lator lymphocytes (C3H/He, H-2 kle and C3H. Q, H-2 qlq) but failed to respond to 
either  donor  (C57BL/Ka)-  or recipient  (BALB/c)-type lymphocytes  (Table  V). 
The response of normal BALB/c lymphocytes against stimulator cells from the 
chimeras  also  documented  the  presence  of allogeneic  cells  in  the  chimeric 
lymphoid organs (Table VI). Tolerance to C57BL/Ka skin allografts could not be 
established in TLI-treated mice by infusing 107 C57BL/Ka BM cells which were 
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TABLZ V 
MLR of Lymph Node Cells from C57BL/Ka-BALB/c  Chimeras Against C57BL/Ka, 
BALB/c, C3H/He, and C3H.Q Stimulator Cells 
Responding  cells* (5 ×  105/culture)  Stimulating  cells (i ×  10e/culture)  cpm  -  SD 
C57BL/Ka-BALB/c chimeras 
C57BL/Ka-BALB/c chimeras 
C57BL/Ka-BALB/c chimeras 
C57BL/Ka-BALB/c chimeras 
C57BL/Ka-BALB/c chimeras 
C57BL/Ka-BALB/c chimera  3,817  __  514 
BALB/c  4,578  -+  448 
C57BL/Ka  5,559  +-  991 
C3H/He  28,424  -+  2,920 
C3H.Q  17,729  --+  3,368 
* Pooled lymph node cells from two chimeras obtained 9 mo after marrow transplantation. 
TABLE VI 
MLR of  Normal BALB/c Lymph Node Cells Against C57BL/Ka-BALB/c Chimera, 
BALB/c, C57BL/Ka, and C3H/He Stimulator Cells 
Responder cells (5  Stimulator cells (1  ×  106/culture)  cpm +  SD 
×  105/culture) 
BALB/c  C57BL/Ka-BALB/c chimera*  67,879  _+  3,403 
BALB/c  BALB/c  1,715  +-  363 
BALB/c  C57BL/Ka  140,749  _+  3,308 
BALB/c  C3H/He  95,110  +__  5,143 
* Pool of lymph node lymphocytes from two chimeras obtained 9 mo after marrow trans- 
plantation. 
Number  and  Function  of PBL  After  TLI.  Serial  determinations  of the 
absolute numbers of circulating T and B lymphocytes and their in vitro function 
were carried out after TLI. A group of 12 treated BALB/c mice served as serial 
blood donors.  Values were compared with those of a  group of 12 age- and sex- 
matched  untreated  BALB/c  controls.  Pools  of blood from  both  groups  were 
obtained simultaneously at various times after TLI. Mean normal values were 
calculated by combining data from the serial bleeds of the control group. There 
were no deaths in the treated group during the 250-day period of observation. 
EFFECT OF TLI ON WBC COUNTS.  Leukopenia at the completion of TLI was 
severe, but rapid recovery occurred and the WBC level after 3 wk was in the 
normal range  (Fig.  3 b).  However, differential counts revealed an inversion of 
the lymphocyte/polymorphonuclear ratio (Fig. 3 b). There was an absolute poly- 
morphonuclear  leukocytosis of up to 4,500/mm  3 (mean  normal  counts,  1,690/ 
mm3), and a concomitant lymphocytopenia. 
The lymphocyte/polymorphonuclear ratio increased steadily, and became nor- 
mal  after  3 mo  (Fig.  3 b).  The  total  number  of WBC was maintained  in  the 
normal range from day 20 to day 250 after TLI. 
T LYMPHOCYTES.  T lymphocytes could not be detected in the peripheral blood 
during the first 27 days after TLI.  Specific killing on day 28 was 14% with the 
anti-Thy 1.2 antiserum, and the absolute T-cell count was 250 cells-ram  3. During 
the next 2 wk a steep rise in the absolute number of T lymphocytes was observed 
(Fig. 3 b). A slow increase in T-cell count continued thereafter, but T lymphocy- 
topenia  (>2 standard deviations below the mean of normal controls) persisted 
for at least 250 days (Fig.  3 b). 
B  LYMPHOCYTES.  Repopulation of Ig-bearing  PBL (B cells) began immedi- (a) 
(b) 
(c) 
(d) 
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Fzo.  3.  (a)  C57BL/Ka skin  allograft survival in  16  BALB/c  mice given TLI  and in  12 
untreated controls. (b) Absolute number of WBC,  lymphocytes,  T cells  (Z~--A), and B 
cells  (A--A) in pooled peripheral blood at different  times after  TLI. Mean normal values 
(_+ standard error)  are represented on the right-hand side.  (c)  One-way mixed lymphocyte 
reaction of  pooled BALB/c PBL against C57BL/Ka lymph node cells  at different  periods 
after  TLI. Mean (- standard error)  syngeneic and allogeneic  responses of  pooled PBL of 
untreated BALB/c mice are represented on the right-hand side. (d) Responses of  pooled 
BALB/c PBL to PHA and Con A at different  periods after  TLI. Responses are  expressed as 
percentages of  the normal responses of pooled PBL of  untreated BALB/c mice examined 
concomitantly. Blood samples were obtained from 12 BALB/c mice given TLI (3,400  rads), 
and from 12 age- and sex-matched control  mice. 
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ately after TLI  (Fig.  3 b).  At day 60 the absolute number of B  lymphocytes 
reached normal levels (1,971 _+ 99/mm3). Significant B lymphocytosis (>2 stan- 
dard deviations above the normal mean) persisted from day 120 (2,700 B lympho- 
cytes/mm  3) through day 250 (2,800 B lymphocytes/mm  3) after TLI. 
PROLIFERATIVE  RESPONSE  Of  PBL  TO  ALLOGENEIC  LYMPHOCYTES  (MLR)  AFTER 
TLI.  PBL  were  unable  to  respond in  the  one-way  MLR against  C57BL/Ka 
lymph node cells for 30 days after TLI (Fig. 3 c).  A  small response was noted at 
day  41  (9,527  _+  383  cpm).  However,  complete  recovery  was  noted  by  day  70 
(19,940  _  436 cpm)  (Fig.  3c). 
PROLIFERATIVE  RESPONSE  OF PBL  TO  PHA  AFTER  TLI.  PBL showed no in vitro 
response above background to PHA during the first 5 wk after TLI (Fig. 3 d). The 
first response to PHA was noted on day 47, when [3H]thymidine uptake was 24% 44  SKIN  AND  MARROW  TRANSPLANTATION  AFTER  TLI 
of that observed in the normal controls (Fig.  3 d).  Diminished PBL responsive- 
ness persisted for 250  days at  40-60%  of simultaneous  normal  control  values 
(Fig.  3 d). 
PROLIFERATIVE  RESPONSE  OF  PBL TO  CON  A  AFTER TLI.  No response to Con A 
was observed for 5 wk after TLI (Fig. 3 d). Thereafter, the response rose to 33% of 
that observed in the matched controls by day 46. The Con A response continued 
to  rise  slowly during  the  remaining  period  of observation,  and  supranormal 
values were measured at 120 (125%) and 250  (255%) days (Fig.  3 d). 
Discussion 
We have previously shown that total lymphoid irradiation  used in the treat- 
ment of Hodgkin's disease is a potent immunosuppressive regimen which elim- 
inates the MLR for 2-3 yr, and induces a T lymphocytopenia which persists for 
at least 10 yr in man (19). Nevertheless, this radiotherapy regimen is associated 
with few severe side effects other than an increased incidence of herpes zoster 
(12).  Fractionated  high  dose total lymphoid irradiation  (total dose 3,400 rads) 
can also be administered to mice by appropriate shielding of vital organs such as 
the lungs and bone marrow (20). After TLI, mice show a long-term T lymphocy- 
topenia,  B  lymphocytosis,  and  transient  loss of the  MLR (20)  similar  to that 
observed in man. Our studies of the immune response of treated mice show that 
the rejection of skin allografts is markedly impaired and that chimerism  after 
infusion  of semiallogeneic  bone  marrow  cells  occurs  for  at  least  6  mo  (21). 
Animals  survive the  irradiation  procedure well and  return  to normal  weight 
within  a  few weeks after treatment  (20,  21).  The present work extends these 
observations, and investigates the use of TLI in the induction of specific trans- 
plantation tolerance in a  completely allogeneic strain combination  (C57BL/Ka 
BALB/c). 
Studies  of the  relationship  between C57BL/Ka skin  allograft  survival  and 
cumulative dose of TLI given to BALB/c recipients show a sharp falloff in mean 
survival time between 3,400 (49.1. days) and 1,400 rads (19.9 days). The degree of 
immunosuppression induced by fractionated irradiation  is also dependent upon 
the extent of the lymphoid tissues included in the radiation fields, since irradia- 
tion (3,400 rads) limited to the tissues below the diaphragm prolonged skin graft 
survival by only 6-7 days. Splenectomy performed before TLI did not result in 
significant prolongation of graft survival as compared to TLI alone. This finding 
was  of considerable  interest,  since  the  majority  of patients  with  Hodgkin's 
disease treated with TLI were splenectomized before radiotherapy. 
In order to determine the contribution of thymic irradiation  to the immuno- 
suppression induced by TLI,  several mice were given TLI with lead shielding 
placed over the  thymus.  C57BL/Ka skin  allograft  survival  was only slightly 
prolonged  [mean  survival  time  (m.s.t.),  18.0  days)]  as  compared  to  controls 
(m.s.t.,  10.7  days),  and  was much  shorter than  in the  group without thymic 
shielding  (m.s.t.,  49.1  days).  This  shows  that  thymic  irradiation  plays  an 
important  role in the long-term suppression of graft rejection induced by TLI. 
However, little further prolongation  of allograft survival was induced in mice 
given TLI and an additional single dose of 2,000 rads to the thymus as compared 
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induced by 3,400 rads received by the gland during TLI. Maruyama and Barclay 
(22) have previously reported that high dose irradiation of the mediastinum can 
result in a  functional thymectomy. 
Semiallogeneic (BALB/c x  C57BL/Ka)FI bone marrow cells transfused intra- 
venously into BALB/c mice treated with TLI survived at least 250 days as judged 
by stable chimerism of PBL and RBC in seven of eight recipients. The majority 
of lymphocytes  in  both  the  blood  and  spleen  were  of donor  origin.  Stable 
semiallogeneic  bone  marrow  chimeras  showed  specific transplantation  toler- 
ance. C57BL/Ka skin allografts survived more than 250 days on these recipients, 
but  C3H/He skin  grafts  transplanted  to the  same  animals  at  200  days were 
rejected within  13 days. 
Allogeneic (C57BL/Ka) bone marrow cells and skin allografts also survived at 
least  250  days  in  8  of 15  BALB/c  recipients  treated  with  TLI  as judged  by 
chimerism of lymphocytes and RBC. Although donor and host contributions to 
PBL counts were about equal,  more than  80% of cells from the spleen,  lymph 
nodes, and BM exposed to irradiation  were of donor origin.  On the other hand, 
most of the cells in unexposed BM were of host origin.  Surprisingly,  allogeneic 
BM recipients  showed no clinical  signs  (ruffled fur,  hunched  back,  diarrhea, 
etc.) of graft vs. host disease and continued to gain weight after the cell infusion. 
The cause of death of 3 of 18 animals after marrow transplantation  is difficult to 
determine,  since  their  autopsy  findings  were  similar  to  those  of untreated 
BALB/c mice  that  succumbed in  our animal  room  at  the  same  time.  Stable 
allogeneic chimeras also showed specific tissue tolerance, since lymph node cells 
obtained from chimeras at 250 days responded to C3H/He cells in the one-way 
MLR, but did not respond to C57BL/Ka cells. 
The increased percentage of stable chimeras induced with semiallogeneic (7/a) 
as  compared  to  allogeneic  (a/as) bone  marrow  cells  may  be  due  to  several 
mechanisms.  One  important  factor  may  be  the  greater  immunogenicity  of 
homozygous as compared to heterozygous grafts (23). It is likely that the seven 
failures observed with allogeneic marrow were due to chronic rejection of these 
marrow cells, since rejection of skin allografts in these animals occurred after 2- 
3 mo. A higher percentage of allogeneic bone marrow "takes" may be obtained 
by increasing the number of infused cells beyond the single dose of 107 cells used 
in  the  present  experiments,  since  Thomas  et  al.  (24)  have  shown  that  the 
successful engraftment of bone marrow in dogs is directly related to the dose of 
infused marrow cells. 
Serial studies of T  lymphocytes in mice given TLI but no allografts showed 
that T lymphocytopenia persists for at least 250 days. The MLR, PHA, and Con 
A  responses  were  eliminated  at  the  completion  of TLI.  However,  the  MLR 
returned to normal levels at about day 70. The response to PHA was depressed 
for at least 250 days, but the Con A response rose to supranormal  levels by 120 
days. 
The alterations in the lymphoid tissues,and immune functions of mice treated 
with TLI are not yet well understood.  However, it is clear that this modality of 
irradiation  produces  changes  which  are  more  complex than just  lymphocyte 
depletion.  Patterns  of lymphocyte repopulation  after TLI are permanently  al- 
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lymphocytes persisit after the absolute lymphocyte count has returned to nor- 
mal. Similar findings were noted in humans treated with TLI (19). 
One hypothesis which is consistent with many of the experimental findings is 
that  TLI  not  only  depletes  lymphocytes, but  also  alters  the  reticular  and 
endothelial structure of the lymphoid tissues (including the thymus) in such a 
way that maturation, homing, and cell-cell interactions of T lymphocytes (and 
perhaps  B  lymphocytes) may be  permanently disturbed.  This  results  in  an 
altered balance in the proportion of T  and B lymphocytes, and reduced T-cell 
subpopulations in the lymphoid tissues (most clearly documented in the periph- 
eral blood). The changes tend to promote the induction of tolerance rather than 
immunity to  antigens introduced during the early recovery phase  after TLI. 
Thus,  allogeneic bone marrow cells infused shortly after TLI induce specific 
transplantation tolerance in host cells. In addition, the donor marrow cells may 
not mature properly in the irradiated lymphoid tissues and become tolerant to 
host antigens, thereby eliminating or minimizing the induction of graft vs. host 
disease. Indirect evidence bearing on these points comes from recent work in our 
laboratory which shows that  two  intraperitoneal  injections of 40  mg bovine 
serum albumin in saline induce a state of tolerance (S. Slavin, I. Zan-Bar, and 
S. Strober, unpublished observations) in BALB/c mice treated with TLI but not 
in normal controls. 
In conclusion, we have developed a  technique for the induction of specific 
tissue transplantation tolerance in adult mice. This technique may have rele- 
vance for clinical organ transplantation,  since (a) the treatment of the recipi- 
ents (TLI) has been shown to be safe in humans, (b) donors and recipients were 
completely allogeneic,  and  (c)  bone  marrow and skin allograft survival was 
permanent (>250 days). 
Summary 
BALB/c  mice  were treated  with  fractionated high  dose  (3,400  rads)  total 
lymphoid irradiation (TLI), and given semiallogeneic (BALB/c × C57BL/Ka) or 
allogeneic (C57BL/Ka) bone marrow and/or skin allografts. TLI alone prolonged 
the mean survival time (m.s.t.) of C57BL/Ka skin grafts to 49.1 days (control, 
10.7 days). Shielding of the thymus during TLI produced only a slight increase 
in graft survival (m.s.t., 19 days). TLI combined with splenectomy was no more 
effective than  TLI  alone.  Infusion  of 107  semiallogeneic or  allogeneic  bone 
marrow  cells  after  TLI  produced  stable  chimeras  in  7/8  and  8/15 recipients, 
respectively. Chimeras were specifically tolerant to donor tissues, since C57BL/ 
Ka skin grafts were accepted for more than 250 days, but third-party (C3H/He) 
skin grafts were rejected rapidly. In addition, chimeric lymphocytes responded 
to C3H/He and C3H.Q but not to C57BL/Ka cells in the one-way mixed leuko- 
cyte reactions. BALB/c C57BL/Ka chimeras showed no clinical evidence of graft 
vs.  host disease. These findings may have application to clinical organ trans- 
plantation, since (a) the recipient treatment (TLI) has already been shown to be 
safe in humans, (b) donors and recipients can be completely allogeneic, and (c) 
bone marrow and skin graft survival was permanent (>250 days). 
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